期刊文献+

HPLC法测定骨髓炎术后引流液中万古霉素的含量 被引量:6

Determination of vancomycin in drainage tissue fluid of osteomyelitis patients by HPLC
原文传递
导出
摘要 目的建立测定骨髓炎载药人工骨植入术后患者引流液中万古霉素含量的HPLC方法。方法以去甲万古霉素为内标,采用CAPCELL PAK C_(18)(250 mm×4.6 mm,5μm)色谱柱,流动相:0.05 moL·L^(-1)磷酸二氢钾溶液(调节pH至3.2)-乙腈(91.5:8.5),DAD检测器,检测波长280 nm,流速1 mL·min^(-1),柱温30℃,引流液经高氯酸沉淀蛋白后进样测定。结果万古霉素含量测定方法的线性范围为23.17~695.10 mg·L^(-1),r=0.9999(n=10),平均回收率102.53%,RSD=2.49%,术后第3天引流液中万古霉素浓度达峰值,累积释放量为45%。结论该方法快速简单,重复性好,适用于引流液中万古霉素浓度的检测。 AIM To establish a HPLC method for the detemaination of vancomycin in drainage tissue fluid of os- teomyelitis patients operated with microsurgical flap implants containing of vancomycin. METHODS The sample was treated by adding internal standard. A CAPCELL PAK C18(250 mm × 4.6 mm, 5 tan) column was adopted with the mo- bile phase: 0.05 moL· L^-1 potassium dihydrogen phosphate(pH 3.2)-acetonitrile( V: V = 91.5:8.5) at the flow rate of 1 mL·min^- 1 and UV detector at 280 nm. The column temperature was 30℃. Drainage tissue fluid samples were prepared by adding pewhloric acid to deposit the protain prior to analysis. RESULTS The linear range was 23.17 - 695.10 mg· L^- 1, r = 0.999 9 ( n = 10). The average recovery rate was 102.53 %, RSD = 2.49 %. The concentration of vancomycin in the drainage tissue fluid at the third day after operation got the peak value, and the cumulative release rate was 45 %. CONCLUSION The optimized method is simple, accurate and specific for the determination of vancomycin in drainage tissue fluid of osteomyelitis patients.
出处 《中国临床药学杂志》 CAS 2013年第1期23-26,共4页 Chinese Journal of Clinical Pharmacy
基金 浙江省科技厅公益性技术应用研究(编号2011C23044) 浙江省医药卫生科技计划(编号2012KYA035)
关键词 骨髓炎 引流液 万古霉素 高效液相色谱法 osteomyelitis drainage tissue fluid vancomycin HPLC
  • 相关文献

参考文献8

二级参考文献29

共引文献51

同被引文献58

  • 1张春,郭峭峰,沈立锋,张晓文,马苟平,俞华军.远端蒂腓肠神经营养血管肌皮瓣的临床应用[J].中华显微外科杂志,2006,29(5):338-340. 被引量:28
  • 2蒋硕民,戚双双,王增寿.高效液相色谱法测定人血浆中万古霉素浓度[J].中国医院药学杂志,2006,26(11):1364-1366. 被引量:15
  • 3Mahboubi M, Bidgoli FG. Antistaphylococcal activity of Zataria muhiflora essential oil and its synergy with vancomycin[J]. Phytomedicine, 2010, 17 (7) :548.
  • 4Urabe K, Naruse K, Hattorli H, et al. In vitro comparison of elution characteristics of vancomycin from calcium phosphate cement and poly- methylmethacrylate [ J ]. J Orthop Sci, 2009,14 ( 6 ) : 784.
  • 5Amador G, Gautier H, Le Mabecque V, et al. In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug de- livery system in a methicillin-resistsnt Staphylococcus aureus rabbit os- teomyelitis experimental model [ J ]. Antimierob Agents Chemother, 2010,54(2) :950.
  • 6Swoboda S,Helbig L, Kommerell M,et al. Bone tissue and plasma con- centrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA[J]. Pharmazie ,2009,64(6):407.
  • 7Chang SS, Tsai MC, Chiu CH, et al. Endoscopically assisted allogeneic bone grafting for atrophic nonunion of femur and tibia[J]. Formosan Jour- nal of Musculoskeletal Disorders,2012,2(3):94.
  • 8McKee MD, Li-Bland EA, Wild LM, et al. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone sub- stitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion [ J ]. J Orthop Trauma, 2010,24(8) :483.
  • 9Malloy KM, Davis GA. Summary of ASHP/IDSA/SIDP vancomycin moni- toring recommendations : a focus on osteomyelitis [ J ]. Orthopedics, 2009,32 (7) :499.
  • 10Assor M. Noncememed total knee arthroplasty with a local prophylactic an- ti-infection agent : a prospective series of 135 cases [ J ] . Can J Surg, 2010, 53(1) :47.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部